Additionally, in the aforementioned mouse model experiment of Chandler et al., administration of the pan-PI3K inhibitor BKM120 in OCCC mice resulted in restraint of tumor cell growth and extension of animal survival, a finding that strengthened the rationale for using PI3K inhibitors in OCCC treatment [75]. The gene discussed is PIK3CA; the disease is neoplasm.